ASTEX PHARMACEUTICALS, INC Retained Earnings
ASTEX PHARMACEUTICALS, INC had Retained Earnings of -$330.22 million as of 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2013-08-09
- 2013-06-30: Retained Earnings (Accumulated Deficit) -$330.22M.
- 2013-03-31: Retained Earnings (Accumulated Deficit) -$326.04M.
- 2012-12-31: Retained Earnings (Accumulated Deficit) -$326.52M.
- 2012-09-30: Retained Earnings (Accumulated Deficit) -$331.05M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2013-06-30 | -$330.22M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$326.04M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$326.52M 10-Q · filed 2013-08-09 |
| 2012-09-30 | -$331.05M 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$329.29M 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$330.53M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$334.77M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$334.99M 10-Q · filed 2011-11-09 |
| 2011-06-30 | -$333.92M 10-Q · filed 2011-08-09 |
| 2010-12-31 | -$340.31M 10-K · filed 2012-03-15 |